3.3. risk factors, prognosis, prevention. several risk factors penile cancer identified, phimosis, chronic penile inflammation, lichen sclerosus, smoking, ultraviolet phototherapy, low socio-economic status, amongst others . patient outcome influenced clinical histologic features. united states seer data 18 cancer registries indicated overall 5-year relative survival 67% significant changes comparing 5-year spans 2000–2014. patients localised disease showed best outcome 81% 5-year relative survival. patients distant metastases worst outcomes 16% 5-year relative survival . human papilloma virus infection main risk factor penile cancer . human papilloma virus deoxyribonucleic acid (dna) identified intraepithelial neoplasia invasive penile cancer tissue samples. hpv virus interacts oncogenes tumour suppressor genes (p16, p53, rb genes) . rate hpv-positivity differs different histological subtypes penile scc. human papilloma virus co-factor carcinogenesis subtypes penile scc, others related hpv. risk penile cancer increased patients condyloma acuminata . sr 52 studies concluded overall hpv prevalence penile cancer 50.8% (95% ci: 44.8–56.7). among hpv-associated carcinomas, basaloid carcinoma showed highest prevalence (84%) followed warty-basaloid carcinoma (75.7%) warty carcinomas (58.7%). histologically hpv-independent carcinomas, hpv prevalence 19.4%. frequent hpv genotypes hpv16 (68.3%, 95% ci: 58.9–77.1), followed low-risk hpv6 genotype (8.1%, 95% ci: 4.0–13.7) . early studies, hpv shown inconsistent association prognosis. one study, significantly better 5-year disease-specific survival (dss) reported hpv-positive vs. hpv-negative cases (93% vs. 78%) , difference lymph node (ln) metastases 10-year survival reported another study . variable relationship outcome remains unexplained studies suggested related specific treatment linked different histologic subtypes . meta-analysis published 2018 reported pooled hr 0.61 penile cancer hpv-positive cases, line head, neck anal cancers , hr 0.34 0.54, respectively. positivity p16 immunohistochemistry (ihc), surrogate hpv activity, showed prognostic value dss (hazard ratio [hr]: 0.45) based two meta-analyses . similar trends reported vulvar anal cancers . significant association incidence penile cervical cancer, although half penile cancer virtually cervical cancer cases linked hpv . female sexual partners patients penile cancer found increased incidence cervical cancer . present, except limited number countries, general recommendation hpv vaccination males different hpv-associated risk patterns penile- cervical cancer. meta-analysis showed incidence anal (risk ratio [rr]: 0.42), oral (rr: 0.16), cervical hpv infections (rr: 0.22) reduced vaccinated groups compared control groups, indicating hpv vaccination leads prevention hpv infection . human papilloma virus vaccination males showed 50% efficacy anal intraepithelial lesions meaningful estimates obtained penile, anal, head neck invasive carcinomas . since 50% invasive penile carcinomas 80% pre-neoplastic lesions hpv-associated, hpv vaccination encouraged . phimosis strongly associated invasive penile cancer [46-49], due associated chronic infections. however, smegma carcinogen . incidence lichen sclerosus relatively high penile cancer patients associated adverse histopathological features, including penile intraepithelial neoplasia (pein). epidemiological risk factors cigarette smoking, low socio-economic status, low level education . neonatal circumcision reduces incidence penile cancer; however, seem reduce risk pein . lowest incidence penile cancer reported israeli jews (0.3/100,000/year). one matched-pair case-control study reported protective effect neonatal circumcision invasive penile cancer (or: 0.41) much weaker analysis restricted men without history phimosis (or: 0.79, 95% ci: 0.29–2) .